Category
An interesting study out of the UK found that the COVID-19 lockdown was a catalyst for many older people to…

In a teleconference announcing the company’s first-quarter 2021 earnings earlier this month, Pfizer laid out its timeline for when different…

News organizations continue to grapple with ways to include in their stories more COVID-19 experts from underrepresented racial and ethnic…

Back in January, Bara Vaida, the AHCJ core topic leader for infectious disease, wrote a helpful post on resources for…

In a deep-dive story for the Center for Public Integrity, a reporting team looked at the risk of contracting the…

There have been a number of stories in the past few weeks about people who became infected with COVID-19, even…

It can be challenging to keep track of all details associated with the authorization, data and ongoing studies related to…

Since the COVID-19 vaccines were authorized by the FDA, one of the big questions has been how well they prevent…

The pandemic laid bare the woeful underfunding of the nation’s public health system as states and localities continue to struggle…

Alarm over the impact of COVID-19 misinformation has been growing, especially with increasing efforts by right-wing groups to spread misinformation…
